220
Views
55
CrossRef citations to date
0
Altmetric
PCOS

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

, , , , , & show all
Pages 258-263 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Muqing Gu, Xiangyan Ruan, Yanqiu Li, Tianhe Li, Chenghong Yin & Alfred O. Mueck. (2022) Effect on the cardiovascular independent risk factor lipoprotein(a) in overweight or obese PCOS patients with ethinyl-estradiol/drospirenone alone or plus orlistat. Gynecological Endocrinology 38:7, pages 598-602.
Read now
Artemis Bousmpoula, Evangelos Benidis, Styliani Demeridou, Rachil Kapeta-Kourkouli, Anthia Chasiakou, Stamatia Chasiakou, Evangelia Kouskouni & Stavroula Baka. (2019) Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles. Gynecological Endocrinology 35:9, pages 803-806.
Read now
Artemis Bousmpoula, Evangelia Kouskouni, Evangelos Benidis, Styliani Demeridou, Rachil Kapeta-Kourkouli, Anthia Chasiakou & Stavroula Baka. (2018) Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles. Gynecological Endocrinology 34:2, pages 153-156.
Read now
S. A. Yilmaz, A. Kebapcilar, M. Koplay, O. S. Kerimoglu, A. T. Pekin, B. Gencoglu, N. U. Dogan & C. Celik. (2015) Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome. Gynecological Endocrinology 31:6, pages 477-482.
Read now
Iliana Tsouma, Evangelia Kouskouni, Stella Demeridou, Maria Boutsikou, Dimitrios Hassiakos, Anthia Chasiakou, Stamatia Hassiakou & Stavroula Baka. (2014) Correlation of visfatin levels and lipoprotein lipid profiles in women with polycystic ovary syndrome undergoing ovarian stimulation. Gynecological Endocrinology 30:7, pages 516-519.
Read now
Michelle P. Rocha, José A. M. Marcondes, Cristiano R. G. Barcellos, Sylvia A. Y. Hayashida, Daniela D. G. Curi, Ângela M. da Fonseca, Vicente R. Bagnoli & Edmund C. Baracat. (2011) Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors. Gynecological Endocrinology 27:10, pages 814-819.
Read now
Teresa Cascella, Stefano Palomba, Francesco Giallauria, Ilario De Sio, Annamaria Colao, Gaetano Lombardi, Marcello Orio & Francesco Orio. (2009) Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. Clinical Lipidology 4:5, pages 623-632.
Read now
Sven M. Carlsen, Sigrun Kjøtrød, Eszter Vanky & Pål Romundstad. (2007) Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome. Acta Obstetricia et Gynecologica Scandinavica 86:2, pages 145-150.
Read now

Articles from other publishers (47)

Aleksandra Szczesnowicz, Anna Szeliga, Olga Niwczyk, Gregory Bala & Blazej Meczekalski. (2023) Do GLP-1 Analogs Have a Place in the Treatment of PCOS? New Insights and Promising Therapies. Journal of Clinical Medicine 12:18, pages 5915.
Crossref
Marlon E. Cerf. (2023) Maternal and Child Health, Non-Communicable Diseases and Metabolites. Metabolites 13:6, pages 756.
Crossref
Walter Masson, Leandro Barbagelata, Martín Lobo, Augusto Lavalle-Cobo, Pablo Corral & Juan Patricio Nogueira. (2023) Plasma Lipoprotein(a) Levels in Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis. High Blood Pressure & Cardiovascular Prevention 30:4, pages 305-317.
Crossref
Yanli Pang, Yue Zhao & Jie Qiao. 2023. Human Reproductive and Prenatal Genetics. Human Reproductive and Prenatal Genetics 531 563 .
Ashok Kumar Shah, Birendra Kumar Yadav, Arpita Suri & Amrendra Kumar Shah. (2022) A study on lipoprotein-a and PAI-1 in women with polycystic ovary syndrome. Hormone Molecular Biology and Clinical Investigation 43:3, pages 357-361.
Crossref
Pooja Suresh Poojary, Guruprasad Nayak, Gangotri Panchanan, Arpitha Rao, Sanjna Das Kundapur, Sneha Guruprasad Kalthur, Srinivas Mutalik, Satish Kumar Adiga, Yulian Zhao, Jamie Bakkum-Gamez, Alice Y Chang, Christopher DeStephano, Mark Sherman, Nagarajan Kannan & Guruprasad Kalthur. (2022) Distinctions in PCOS Induced by Letrozole Vs Dehydroepiandrosterone With High-fat Diet in Mouse Model. Endocrinology 163:9.
Crossref
Aya Mousa, Kevin Huynh, Stacey J Ellery, Boyd J Strauss, Anju E Joham, Barbora de Courten, Peter J Meikle & Helena J Teede. (2022) Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 107:5, pages e1987-e1999.
Crossref
Isabel Gálvez, María Carmen Navarro, Leticia Martín-Cordero, Eduardo Otero, María Dolores Hinchado & Eduardo Ortega. (2022) The Influence of Obesity and Weight Loss on the Bioregulation of Innate/Inflammatory Responses: Macrophages and Immunometabolism. Nutrients 14:3, pages 612.
Crossref
Weixuan Chen & Yanli Pang. (2021) Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites 11:12, pages 869.
Crossref
Chang-Zhu Pei, Lan Jin & Kwang-Hyun Baek. (2021) Pathogenetic analysis of polycystic ovary syndrome from the perspective of omics. Biomedicine & Pharmacotherapy 142, pages 112031.
Crossref
Nishaf Manzar, Safwan Ahmad khan, Najum Fatima, Mehr un Nisa, Muhammad Haseeb Ahmad, Muhammad Inam Afzal, Hafiz Fahad Ullah Saeed, Muhammad Imran, Faqir Muhammad Anjum & Muhammad Sajid Arshad. (2021) Exploring the prophylactic role of soy isoflavones against polycystic ovarian syndrome. Food Science & Nutrition 9:9, pages 4738-4744.
Crossref
Simon Alesi, Drishti Ghelani & Aya Mousa. (2021) Metabolomic Biomarkers in Polycystic Ovary Syndrome: A Review of the Evidence. Seminars in Reproductive Medicine 39:03/04, pages 102-110.
Crossref
Wei Zheng, Wenyu Huang, Li Zhang, Zhihong Tian, Qi Yan, Teng Wang, Lirui Zhang & Guanghui Li. (2019) Early pregnancy metabolic factors associated with gestational diabetes mellitus in normal-weight women with polycystic ovary syndrome: a two-phase cohort study. Diabetology & Metabolic Syndrome 11:1.
Crossref
Qi Liu, Yuan-jie Xie, Li-hua Qu, Meng-xia Zhang & Zhong-cheng Mo. (2019) Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwanese Journal of Obstetrics and Gynecology 58:4, pages 447-453.
Crossref
Xuemei Fan, Jianfa Jiang, Zhiqiang Huang, Jumei Gong, Yiming Wang, Wei Xue, Yan Deng, Yanfang Wang, Tingping Zheng, Aijun Sun & Guoan Luo. (2018) UPLC/Q‑TOF‑MS based plasma metabolomics and clinical characteristics of polycystic ovarian syndrome. Molecular Medicine Reports.
Crossref
Panagiotis Anagnostis, Basil C. Tarlatzis & Robert P. Kauffman. (2018) Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism 86, pages 33-43.
Crossref
Sibel Ozler, Efser Oztas, Aytekin Tokmak, Merve Ergin, Esra Isci, Funda Eren, Selcen Pehlivan, Salim Neselioglu & Nafiye Yılmaz. (2015) The association of thiol/disulphide homeostasis and lipid accumulation index with cardiovascular risk factors in overweight adolescents with polycystic ovary syndrome. Clinical Endocrinology 84:4, pages 516-523.
Crossref
G. Nucette-Pirela, H. Luz-Araujo, M. Guerra Velásquez, E. Reyna-Villasmil, J. Mejia-Montilla, N. Reyna-Villasmil, I. Suárez-Torres & A. Bravo-Henríquez. (2016) Atorvastatina y concentraciones de proteína C reactiva en mujeres con síndrome de ovarios poliquísticos y sobrepeso. Clínica e Investigación en Ginecología y Obstetricia 43:2, pages 63-67.
Crossref
Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Adnan Abbuthalha, Parneet Kaur, Jasmeen Visla, Sidika Karakas & Lars Berglund. (2015) Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clinical Endocrinology 84:2, pages 229-235.
Crossref
Zatollah Asemi, Maryam Karamali & Ahmad Esmaillzadeh. (2014) Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: A randomized double‐blind placebo‐controlled clinical trial. Molecular Nutrition & Food Research 58:7, pages 1465-1473.
Crossref
N. Güdücü, U. Görmüş, E. Alp, Z.N. Kavak & İ. Dünder. (2014) Reciprocal Action of Pentraxin-3 and CRP in Women with Polycystic Ovary Syndrome. European Journal of Inflammation 12:1, pages 161-166.
Crossref
Mora Murri, Manuel Luque-Ramírez, María Insenser, Miriam Ojeda-Ojeda & Hector F. Escobar-Morreale. (2013) Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Human Reproduction Update 19:3, pages 268-288.
Crossref
Jin Ju KimYoung Min Choi. (2013) Dyslipidemia in women with polycystic ovary syndrome. Obstetrics & Gynecology Science 56:3, pages 137.
Crossref
Konstantinos A. Toulis, Dimitrios G. Goulis, Gesthimani Mintziori, Evangelia Kintiraki, Evangelos Eukarpidis, Sophia-Anastasia Mouratoglou, Antigoni Pavlaki, Stavros Stergianos, Maria Poulasouchidou, Thrasivoulos G. Tzellos, Anastasios Makedos, Michael Chourdakis & Basil C. Tarlatzis. (2011) Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome. Human Reproduction Update 17:6, pages 741-760.
Crossref
Hakan Coksuer, Mustafa Koplay, Fatih Oghan, Berna Haliloglu & Nadi Keskin. (2011) Evaluation of carotid wall thickness and vertebro-basilar system insufficiency in patients with obese polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 37:8, pages 997-1003.
Crossref
Constantin A. Dasanu, Bernard A. ClarkIIIIII, Thomas E. Ichim & Doru T. Alexandrescu. (2011) Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk. Southern Medical Journal 104:3, pages 174-178.
Crossref
S. L. Mumford, E. F. Schisterman, A. M. Siega-Riz, A. J. Gaskins, A. Z. Steiner, J. L. Daniels, A. F. Olshan, M. L. Hediger, K. Hovey, J. Wactawski-Wende, M. Trevisan & M. S. Bloom. (2010) Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation. Human Reproduction 26:2, pages 423-430.
Crossref
N. PhelanA. O'Connor, T. Kyaw-TunN. CorreiaG. BoranH. M. Roche & J. Gibney. (2010) Lipoprotein Subclass Patterns in Women with Polycystic Ovary Syndrome (PCOS) Compared with Equally Insulin-Resistant Women without PCOS. The Journal of Clinical Endocrinology & Metabolism 95:8, pages 3933-3939.
Crossref
Anastasios MakedosDimitrios G. Goulis, Alexis Papanikolaou & Dimitrios Panidis. (2010) Serum High-Sensitivity C-Reactive Protein and Homocysteine Changes During Hormonal Therapy in Women With Polycystic Ovary Syndrome: A Prospective, Matched Study. Angiology 61:6, pages 595-601.
Crossref
Yanling Wu, Junyun Li, Jusu Wang, Qiuju Si, Jianping Zhang, Ye Jiang & Li Chu. (2009) Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet. Journal of Ethnopharmacology 122:3, pages 509-516.
Crossref
Anne Donnadieu, Maud Pasquier, Céline Meynant, Jean-Noël Hugues & Isabelle Cédrin-Durnerin. (2009) Nutrition et infertilité féminine. Cahiers de Nutrition et de Diététique 44:1, pages 33-41.
Crossref
K. Berneis, M. Rizzo, M. Hersberger, G. B. Rini, G. Di Fede, I. Pepe, G. A Spinas & E. Carmina. (2009) Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice 63:1, pages 56-62.
Crossref
E. Kassi & E. Diamanti-Kandarakis. (2014) The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome. Journal of Endocrinological Investigation 31:12, pages 1124-1131.
Crossref
H.E. Westerveld, M. Hoogendoorn, A.W.F. de Jong, A.J. Goverde, B.C.J.M. Fauser & G.M. Dallinga-Thie. (2008) Cardiometabolic abnormalities in the polycystic ovary syndrome: Pharmacotherapeutic insights. Pharmacology & Therapeutics 119:3, pages 223-241.
Crossref
T. Forges, H. Pellanda, C. Diligent, P. Monnier & J.-L. Guéant. (2008) Les folates : quel impact sur la fertilité ?. Gynécologie Obstétrique & Fertilité 36:9, pages 930-939.
Crossref
Nafiye Yilmaz, Mine Pektas, Esra Tonguc, Sevtap Kilic, Cavidan Gulerman, Tayfun Gungor & Leyla Mollamahmutoglu. (2008) The correlation of plasma homocysteine with insulin resistance in polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research 34:3, pages 384-391.
Crossref
Nesibe Andiran & Nursen Yordam. (2008) Lipoprotein(a) levels in girls with premature adrenarche. Journal of Paediatrics and Child Health 44:3, pages 138-142.
Crossref
Olivier Valkenburg, Regine P. M. Steegers-Theunissen, Huberdina P. M. Smedts, Geesje M. Dallinga-Thie, Bart C. J. M. Fauser, Egbertine H. Westerveld & Joop S. E. Laven. (2008) A More Atherogenic Serum Lipoprotein Profile Is Present in Women with Polycystic Ovary Syndrome: A Case-Control Study. The Journal of Clinical Endocrinology & Metabolism 93:2, pages 470-476.
Crossref
Yilmaz Sahin, Kursad Unluhizarci, Ayse Yilmazsoy, Ali Yikilmaz, Ercan Aygen & Fahrettin Kelestimur. (2007) The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Clinical Endocrinology 67:6, pages 904-908.
Crossref
Ozgur Baris Gul, Asli Somunkiran, Oguz Yucel, Fuat Demirci & Ismail Ozdemir. (2007) The effect of ethinyl estradiol–cyproterone acetate treatment on homocysteine levels in women with polycystic ovary syndrome. Archives of Gynecology and Obstetrics 277:1, pages 25-30.
Crossref
Thierry Forges, P. Monnier-Barbarino, J.M. Alberto, R.M. Guéant-Rodriguez, J.L. Daval & J.L. Guéant. (2007) Impact of folate and homocysteine metabolism on human reproductive health. Human Reproduction Update 13:3, pages 225-238.
Crossref
Lina Wang, Qiao Ke, Wensen Chen, Jianming Wang, Yongfei Tan, Yan Zhou, Zhaolai Hua, Weiliang Ding, Juying Niu, Jing Shen, Zuofeng Zhang, Xinru Wang, Yaochu Xu & Hongbing Shen. (2007) Polymorphisms of MTHFD, Plasma Homocysteine Levels, and Risk of Gastric Cancer in a High-Risk Chinese Population. Clinical Cancer Research 13:8, pages 2526-2532.
Crossref
Tessa G Lebinger. (2007) Metformin and polycystic ovary syndrome. Current Opinion in Endocrinology, Diabetes & Obesity 14:2, pages 132-140.
Crossref
Francesco OrioJr.Jr., Evanthia Diamanti-Kandarakis & Stefano Palomba. 2007. Insulin Resistance and Polycystic Ovarian Syndrome. Insulin Resistance and Polycystic Ovarian Syndrome 181 190 .
Francesco Orio & Stefano Palomba. 2007. Androgen Excess Disorders in Women. Androgen Excess Disorders in Women 325 331 .
Heather K. Vincent, Cheryl Bourguignon & Kevin R. Vincent. (2012) Resistance Training Lowers Exercise‐Induced Oxidative Stress and Homocysteine Levels in Overweight and Obese Older Adults. Obesity 14:11, pages 1921-1930.
Crossref
Preethi Srikanthan, Stanley Korenman & Susan Davis. (2006) Polycystic Ovarian Syndrome: the Next Cardiovascular Dilemma in Women?. Endocrinology and Metabolism Clinics of North America 35:3, pages 611-631.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.